Collectively, these findings suggest that the induction of CHAC1 expression by tramadol and O-desmethyltramadol may be mediated through elevated ROS levels rather than changes in glutathione redox balance, highlighting a potential oxidative stress-related mechanism underlying their effects in breast cancer cells. The gene discussed is CHAC1; the disease is breast carcinoma.